Samsara BioCapital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001744967 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value: $174M (100.0% shares, 0.0% debt)

Holdings (28)

Intercept Pharmaceuticals Inc 14.6%
Value $25.42M Shares 403,688 Est. Cost $88.27 Unrealized
Principia Biopharma Inc 13.7%
Value $23.81M Shares 401,046 Est. Cost $34.91 Unrealized
Springworks Therapeutics Inc 9.7%
Value $16.88M Shares 625,281 Est. Cost $21.68 Unrealized
Odonate Therapeutics Inc 8.3%
Value $14.43M Shares 522,637 Est. Cost $14.81 Unrealized
Allakos Inc 6.9%
Value $12.05M Shares 270,965 Est. Cost $51.45 Unrealized
Sutro BioPharma Inc 6.6%
Value $11.48M Shares 1,125,579 Est. Cost $9.02 Unrealized
Atreca Inc 5.7%
Value $9.878M Shares 596,838 Est. Cost $18.84 Unrealized
Syros Pharmaceuticals Inc 5.5%
Value $9.599M Shares 1,726,603 Est. Cost $6.82 Unrealized
LQDA Liquidia Technologies Inc 2.7%
Value $4.775M Shares 1,013,773 Est. Cost $6.51 Unrealized -23.8%
Hookipa Pharma Inc 2.5%
Value $4.375M Shares 530,245 Est. Cost $6.73 Unrealized
RYTM Rhythm Pharmaceuticals Inc 2.4%
Value $4.205M Shares 276,289 Est. Cost $17.90 Unrealized 0.0%
Millendo Therapeutics Inc 2.3%
Value $3.967M Shares 751,301 Est. Cost $6.81 Unrealized
Bellus Health Inc 2.3%
Value $3.917M Shares 394,431 Est. Cost $7.55 Unrealized
Pieris Pharmaceuticals Inc 2.1%
Value $3.694M Shares 1,620,249 Est. Cost $2.86 Unrealized
Aimmune Therapeutics, Inc. 1.9%
Value $3.354M Shares 232,571 Est. Cost $14.42 Unrealized
Aravive Inc 1.9%
Value $3.318M Shares 576,066 Est. Cost $5.87 Unrealized
Iveric Bio, Inc. 1.7%
Value $2.967M Shares 862,552 Est. Cost $7.61 Unrealized
ACRS Aclaris Therapeutics, Inc. 1.6%
Value $2.712M Shares 2,608,117 Est. Cost $1.36 Unrealized 0.0%
Sunesis Pharmaceuticals Inc 1.4%
Value $2.464M Shares 5,938,215 Est. Cost $0.75 Unrealized
RCKT Rocket Pharmaceuticals Inc 1.0%
Value $1.788M Shares 128,197 Est. Cost $19.80 Unrealized 0.0%
UROV Urovant Sciences Ltd 0.8%
Value $1.452M Shares 157,480 Est. Cost $6.59 Unrealized
KALV KalVista Pharmaceuticals Inc 0.7%
Value $1.287M Shares 168,174 Est. Cost $18.15 Unrealized -25.7%
Catabasis Pharmaceuticals Inc 0.7%
Value $1.245M Shares 300,000 Est. Cost $4.37 Unrealized
Bluebird Bio Inc 0.7%
Value $1.139M Shares 24,790 Est. Cost $45.95 Unrealized
Portola Pharmaceuticals Inc 0.7%
Value $1.139M Shares 159,772 Est. Cost $7.13 Unrealized
Akero Therapeutics, Inc. 0.6%
Value $1.06M Shares 50,000 Est. Cost $21.20 Unrealized
Amarin Corp PLC 0.4%
Value $781K Shares 195,195 Est. Cost $4.00 Unrealized
Kala Pharmaceuticals Inc 0.3%
Value $563K Shares 64,102 Est. Cost $8.78 Unrealized